Evaluating Exercise as a Therapy for Hip Osteoarthritis
Is exercise an effective therapy for hip osteoarthritis? A comprehensive evaluation of clinical evidence reveals that structured physical activity provides small improvements in joint function and pain relief for most adults, though these changes may not always feel pronounced in everyday life. Hip osteoarthritis is a common, long-lasting condition where the cartilage cushioning the hip joint wears down over time, resulting in persistent joint pain, stiffness, and difficulty executing routine movements such as climbing stairs or standing up from a chair.
To understand what current medical literature actually demonstrates, researchers conducted a comprehensive review of clinical trials assessing land-based exercise programmes for adults with hip osteoarthritis. The findings update previous evaluations and outline clear parameters regarding what patients can realistically expect from physical therapy and structured workouts.
Global Scope and Clinical Trial Demographics
The evaluation encompasses 18 distinct clinical studies involving a total of 1,368 adult participants. The cohort was predominantly female, at 63 percent, with ages ranging from 53 to 74 years old. These trials spanned multiple countries, including Australia, Canada, Denmark, Finland, Germany, Ireland, Italy, the Netherlands, New Zealand, Norway, Sweden, and the United States. Intervention program durations varied widely, lasting anywhere from two weeks to 52 weeks, with most trials evaluating outcomes immediately upon program completion.
Comparing Physical Activity Against Dummy Treatments
When comparing exercise against a dummy treatment, clinical data from two studies involving 123 adults indicates that physical activity may have little to no effect on pain. However, it may improve joint function slightly. Measured on a scale of 0 to 100—where a 13-point shift represents a meaningful clinical difference—participants who exercised scored 7.4 points better than those receiving a dummy treatment. Available studies did not report significant findings regarding well-being or overall treatment success, and researchers remain uncertain whether exercise alters the frequency of unwanted events compared to a dummy intervention.
Measuring Outcomes Against Control Groups
When evaluated against no treatment, usual care, or limited educational interventions across 10 studies involving 494 adults, exercise probably leads to small improvements in both pain and joint function. On the same 0-to-100 scoring scale, individuals who engaged in structured exercise scored 7.2 points better for pain—where a 12-point gap signifies a meaningful change—and 8.8 points better for joint function compared to control groups. Despite these numerical gains, researchers note these differences may not translate into noticeable shifts during daily activities. Furthermore, exercise probably exerts little to no effect on overall well-being in this comparison.
Combined Therapies and Methodological Limitations
Combining exercise with an alternative primary treatment yields a different pattern. Across seven studies involving 751 participants, adding physical activity to another therapy probably produces little to no effect on pain, joint function, or general well-being. It may, however, slightly reduce the risk of unwanted events compared to receiving the other treatment alone. Across all trial comparisons, researchers found that participants engaging in exercise were generally no more likely to discontinue treatment than control groups.
Several limitations qualify the existing body of evidence. Because study populations included individuals with varying levels of pain and physical disability, results broadly apply to most older adults with hip osteoarthritis. However, younger adults were severely underrepresented in these trials, meaning the findings may not translate directly to younger demographics. Additionally, because participants in most trials were aware they were receiving exercise therapy, and because pain and physical function were largely self-reported, the intervention might appear more effective in trial settings than it proves to be in clinical practice. Investigators report moderate confidence in certain outcomes and lower confidence in others due to small sample sizes and variability across trial designs.
The medical community continues to advocate for further, high-quality investigations specifically targeting hip osteoarthritis populations to refine therapeutic guidelines.